drugset / Trial / NCT01533116
Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the effect of BIA 9-1067 in steady-state conditions on the levodopa pharmacokinetics
Timeline
- Start
- 2009-03
- Primary completion
- 2009-08
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 5 mg | — |
| Subject | Opicapone | Small molecule | 15 mg | — |
| Subject | Opicapone | Small molecule | 30 mg | — |
| Subject | levodopa/benserazide | Unknown | — | — |
| Subject | levodopa/carbidopa | Unknown | — | — |